EmVenio Research establishes decentralized clinical trial sites in underserved communities, utilizing community engagement and data analytics to enhance patient recruitment and retention. This approach addresses the lack of access to clinical trials for diverse populations, improving enrollment rates and ensuring that underrepresented groups are included in medical research.
Funding
$9.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Underrepresented communities often lack access to clinical trials, leading to insufficient data on diverse populations and hindering medical advancements that benefit everyone. Traditional clinical trial recruitment methods often fail to engage these communities, resulting in low enrollment rates and a lack of inclusivity in medical research.
Solution
EmVenio Research establishes community-based clinical trial sites and employs patient-focused solutions to provide inclusive trial opportunities for diverse and underrepresented populations. By strategically locating research sites in historically underserved regions and utilizing community engagement initiatives, EmVenio connects individuals to relevant clinical studies. The company combines community resources with data analytics to improve patient recruitment and retention, ensuring that clinical trials reflect the diversity of the patient population. EmVenio's approach aims to break down barriers, create collaborative opportunities, and foster a supportive environment for participation in clinical trials.
Target Audience
EmVenio's primary customers include pharmaceutical sponsors, clinical research organizations (CROs), and healthcare providers seeking to improve clinical trial access and representation for diverse patient populations.
Features
- Strategically located clinical research sites in underrepresented communities.
- Community-based hospitals supported by experienced clinicians and expert Principal Investigators (PIs).
- Mobile research centers that bring trials directly to participants through flexible, hybrid solutions.
- Patient engagement initiatives combining community resources with data analytics for targeted recruitment.
- Virtual visits to increase patient convenience and accessibility.
- Focus on therapeutic areas with high unmet needs in diverse populations.